Abstract
To investigate the association between human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV), simultaneous determinations of HIV antigen (HIV Ag) p24 and EBV DNA were performed in lymphocyte culture supernatants from 63 individuals at risk of HIV infection. In vitro data, together with HIV immune status results, were subjected to a statistical analysis. HIV infection was identified in 49 patients (78 %); of these, in vitro EBV DNA was found in 44 individuals (90 %), while in only 3 of the 14 non-infected ones (21 %). Statistical analysis demonstrated a close relationship between evidence of HIV infection and in vitro detection of EBV DNA (87.3 % concordant with 95 % confidence interval: 76.5 %–94.5 %). Furthermore, a strong dependence was revealed between the presence of EBV DNA and HIV Ag in culture (p<0.00001). These results indicate the existence of in vitro viral interactions, with likely in vivo implications in the pathogenesis and evolution of HIV infection.
Similar content being viewed by others
References
Hirsch MS, Schooley RT, Ho DD, Kaplan JC: Possible viral interactions in the acquired immunodeficiency syndrome. Reviews of Infectious Diseases 1984, 6: 726–731.
Tremblay M, Gornitsky M, Wainberg MA: Active replication of human immunodeficiency virus type 1 by peripheral blood mononuclear cells following coincubation with herpesviruses. Journal of Medical Virology 1989, 29: 109–114.
Andiman WA, Martin WA, Rubinstein A, Pahwa S, Eastman R, Katz B, Pitt J, Miller G: Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS. Lancet 1985, 8469: 1390–1393.
Montagnier L: Lymphadenopathy associated virus: its role in the pathogenesis of AIDS and related diseases. Progress in Allergy 1986, 37: 46–64.
List AF, Greco FA, Vogler LB: Lymphoproliferative diseases in immunocompromised hosts: the role of Epstein-Barr virus. Journal of Clinical Oncology 1987, 5: 1673–1689.
Sumaya CV, Boswell RN, Ench Y, Kisner DL, Hersh EM, Reuben JM, Mansell WA: Enhanced serological and virological findings of Epstein-Barr virus in patients with AIDS and AIDS related complex. Journal of Infectious Diseases 1986, 154: 864–870.
Barré-Sinoussi F, Mathur-Wagh U, Rey F, Brun-Vezinet F, Yancovitz SR, Rouzioux C, Montagnier L, Mildvan D, Chermann JC: Isolation of lymphadenopaphy-associated virus and detection of LAV antibodies from US patients with AIDS. Journal of the American Medical Association 1985, 253: 1737–1739.
Anderson MLM, Young BD: Quantitative filter hybridisation. In: Hames BD, Higgins SJ (ed): Nucleic acid hybridization. A practical approach. IRL Press, Washington, DC, 1987, p. 73–111.
Imagawa DT, Lee MH, Wolinski SM, Sano K, Morales F, Kwok S, Sninski JJ, Nishanian PG, Giorgi J, Fahey JL, Dudley J, Visscher BR, Detels R: Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods. New England Journal of Medicine 1989, 320: 1458–1462.
Baltimore D, Feinberg MB: HIV revealed. Toward a natural history of the infection. New England Journal of Medicine 1989, 321: 1673–1675.
Haseltine WA: Silent HIV infections. New England Journal of Medicine 1989, 320: 1487–1489.
Rahman MA, Kingsley LA, Breinig MK, Ho M, Armstrong JA, Atchison RW, Lyter DW, Rinaldo CR: Enhanced antibody responses to Epstein-Barr virus in HIV homosexual men. Journal of Infectious Diseases 1989, 159: 472–479.
Skolnik PR, Kosloff BR, Hirsch MS: Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus. Journal of Infectious Diseases 1988, 157: 508–514.
Kenney S, Kamine J, Markovitz D, Fenrick R, Pagano J: An Epstein-Barr virus immediate-early gene product transactivates gene expression from the human immunodeficiency virus long terminal repeat. Proceedings of the National Academy of Science, USA 1988, 85: 1652–1656.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lardelli, P., Steinberg, S.M., Campelo, C. et al. Evidence of an in vitro association between human immunodeficiency virus antigen P24 and Epstein-Barr virus DNA. Eur. J. Clin. Microbiol. Infect. Dis. 11, 157–161 (1992). https://doi.org/10.1007/BF01967068
Issue Date:
DOI: https://doi.org/10.1007/BF01967068